Shares of Fluidigm Corporation (FLDM) stock, a biotechnology tools provider, were continued the downtrend on the Friday aftermarket session after dropping by 1.49% at the
The biotech firm has made a notable development for its COVID-19 test. While the stock soars as FLDM nears the anticipated results for the full
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.